Article de revue
The drug and vaccine landscape for neglected diseases (2000—11): a systematic assessment
The study concludes that there is a persistent insufficiency in drug and vaccine development for neglected diseases. Nevertheless, these and other data show a slight improvement during the past 12 years in new therapeutics development and registration. However, for many neglected diseases, new therapeutic products urgently need to be developed and delivered to improve control and potentially achieve elimination.
Auteurs
Langues
- Anglais
Journal
The Lancet Global Health
Volume
6
Type
Article de revue
Catégories
- Initiatives mondiales
